4//SEC Filing
Feder Julie B 4
Accession 0000899243-21-042083
CIK 0001501796other
Filed
Oct 28, 8:00 PM ET
Accepted
Oct 29, 7:24 PM ET
Size
7.4 KB
Accession
0000899243-21-042083
Insider Transaction Report
Form 4
Feder Julie B
Chief Financial Officer
Transactions
- Award
Stock Option (Right to Buy)
2021-10-28+112,500→ 112,500 totalExercise: $14.00Exp: 2031-10-27→ Common stock (112,500 underlying) - Award
Common Stock
2021-10-28+26,250→ 26,250 total
Footnotes (2)
- [F1]These shares were acquired pursuant to a restricted stock unit award under the Company's 2021 Stock Option and Incentive Plan. Each restricted stock unit represents the right to receive one share of the Company's common stock. These restricted stock units vest in four substantially equal annual installments beginning on the one year anniversary of the date of grant.
- [F2]The shares underlying this option vest as follows: 25% of the shares vest on the first anniversary of October 28, 2021 with the remainder vesting thereafter pro-rata in 36 monthly installments.
Documents
Issuer
Aura Biosciences, Inc.
CIK 0001501796
Entity typeother
Related Parties
1- filerCIK 0001710237
Filing Metadata
- Form type
- 4
- Filed
- Oct 28, 8:00 PM ET
- Accepted
- Oct 29, 7:24 PM ET
- Size
- 7.4 KB